MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 12-23-2023
Natus Medical Incorporated Operating Expenses 2011-2026 | NTUS
Annual Operating Expenses Natus Medical Incorporated
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 250 M | 233 M | 263 M | 291 M | 272 M | 178 M | 172 M | 169 M | 168 M | 158 M | 121 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 291 M | 121 M | 207 M |
Quarterly Operating Expenses Natus Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 61.2 M | - | 59.2 M | 60.4 M | 62 M | - | 57.5 M | 52.6 M | 66 M | - | 65.5 M | 64.8 M | 105 M | - | 80 M | 78.8 M | 74.4 M | - | 65.7 M | 72.4 M | 65.3 M | - | 42.9 M | 43.5 M | 43 M | - | 42.3 M | 43.4 M | 40.3 M | - | 42.8 M | 40.7 M | 41.2 M | - | 42.2 M | 42.2 M | 44.4 M | - | 49.1 M | 33.7 M | 32.9 M | - | 28.6 M | 29.9 M | 29.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 105 M | 28.6 M | 53 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.11 | - | $ 3.29 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 10.42 | - | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 3.91 | - | $ 828 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 37.41 | - | $ 1.16 B | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 12.6 | - | $ 1.89 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 8.38 | - | $ 602 M |  Israel |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.96 | 1.02 % | $ 148 M |  France |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 69.79 | - | $ 103 B | USA |
 |
Establishment Labs Holdings
ESTA
|
185 M | $ 63.48 | - | $ 1.88 B |  Costa-rica |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.19 | - | $ 1.33 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.65 | -8.13 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.33 | - | $ 21.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.03 | - | $ 298 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
LivaNova PLC
LIVN
|
697 M | $ 61.43 | - | $ 3.35 B |  Britain |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.42 | 0.22 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 13.43 | - | $ 868 M | Israel |
 |
MiMedx Group
MDXG
|
277 M | $ 4.41 | - | $ 652 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.59 | - | $ 152 M | Israel |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 109.95 | - | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 9.81 | - | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 261.24 | - | $ 7.37 B | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 224.66 | - | $ 15.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.01 | - | $ 694 M | USA |
 |
Profound Medical Corp.
PROF
|
33 M | $ 5.71 | - | $ 180 M | Canada |
 |
AxoGen
AXGN
|
121 M | $ 32.84 | - | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 169.45 | - | $ 12.7 B | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 32.76 | - | $ 4.88 K | USA |
 |
AVITA Medical
RCEL
|
101 M | $ 4.62 | 5.0 % | $ 129 M |  Australia |